Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatemeh Elahian

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Oncology Research|November 17, 2009
Dexamethasone downregulates BCRP mRNA and protein expression in breast cancer cell linesFatemeh Elahian, Fatemeh Kalalinia, Javad Behravan
Journal of Cancer Research and Clinical Oncology|April 28, 2010
Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell linesFatemeh Kalalinia, Fatemeh Elahian, Javad Behravan
Drug and Chemical Toxicology|March 24, 2010
Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell linesFatemeh Elahian, Fatemeh Kalalinia, Javad Behravan
International Journal of Biological Macromolecules|September 1, 2024
Innovative genetic scissor strategies and their applications in cancer treatment and prevention: CRISPR modules and challengesSayedeh Azimeh Hosseini, Fatemeh Elahian, Seyed Abbas Mirzaei
Iranian Journal of Pharmaceutical Research : IJPR|January 15, 2015
Celecoxib Up Regulates the Expression of Drug Efflux Transporter ABCG2 in Breast Cancer Cell LinesFatemeh Kalalinia, Fatemeh Elahian, Fatemeh Mosaffa, et al.
Inflammopharmacology|October 18, 2020
Pharmacodynamic mechanisms of anti-inflammatory drugs on the chemosensitization of multidrug-resistant cancers and the pharmacogenetics effectivenessNeda Gholamian Dehkordi, Seyed Abbas Mirzaei, Fatemeh Elahian
Scientific Reports|October 16, 2021
siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cellsRazieh Heidari, Pegah Khosravian, Seyed Abbas Mirzaei, et al.
Life Sciences|September 9, 2019
Inflammatory pathway interactions and cancer multidrug resistance regulationSeyed Abbas Mirzaei, Farideh Dinmohammadi, Akram Alizadeh, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 30, 2016
High-throughput bioaccumulation, biotransformation, and production of silver and selenium nanoparticles using genetically engineered Pichia pastorisFatemeh Elahian, Somayeh Reiisi, Arman Shahidi, et al.
Critical Reviews in Biotechnology|November 2, 2012
Human cytochrome b5 reductase: structure, function, and potential applicationsFatemeh Elahian, Zargham Sepehrizadeh, Bahareh Moghimi, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Oncology Research|November 17, 2009
Dexamethasone downregulates BCRP mRNA and protein expression in breast cancer cell linesFatemeh Elahian, Fatemeh Kalalinia, Javad Behravan
Journal of Cancer Research and Clinical Oncology|April 28, 2010
Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell linesFatemeh Kalalinia, Fatemeh Elahian, Javad Behravan
Drug and Chemical Toxicology|March 24, 2010
Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell linesFatemeh Elahian, Fatemeh Kalalinia, Javad Behravan
International Journal of Biological Macromolecules|September 1, 2024
Innovative genetic scissor strategies and their applications in cancer treatment and prevention: CRISPR modules and challengesSayedeh Azimeh Hosseini, Fatemeh Elahian, Seyed Abbas Mirzaei
Iranian Journal of Pharmaceutical Research : IJPR|January 15, 2015
Celecoxib Up Regulates the Expression of Drug Efflux Transporter ABCG2 in Breast Cancer Cell LinesFatemeh Kalalinia, Fatemeh Elahian, Fatemeh Mosaffa, et al.
Inflammopharmacology|October 18, 2020
Pharmacodynamic mechanisms of anti-inflammatory drugs on the chemosensitization of multidrug-resistant cancers and the pharmacogenetics effectivenessNeda Gholamian Dehkordi, Seyed Abbas Mirzaei, Fatemeh Elahian
Scientific Reports|October 16, 2021
siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cellsRazieh Heidari, Pegah Khosravian, Seyed Abbas Mirzaei, et al.
Life Sciences|September 9, 2019
Inflammatory pathway interactions and cancer multidrug resistance regulationSeyed Abbas Mirzaei, Farideh Dinmohammadi, Akram Alizadeh, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 30, 2016
High-throughput bioaccumulation, biotransformation, and production of silver and selenium nanoparticles using genetically engineered Pichia pastorisFatemeh Elahian, Somayeh Reiisi, Arman Shahidi, et al.
Critical Reviews in Biotechnology|November 2, 2012
Human cytochrome b5 reductase: structure, function, and potential applicationsFatemeh Elahian, Zargham Sepehrizadeh, Bahareh Moghimi, et al.
Pageof 4